Condition: OCD · Obsessive-Compulsive Disorder (OCD) · Obsessive-Compulsive Disorder · Sponsor: Sunnybrook Health Sciences Centre
This study evaluates the safety, feasibility, and preliminary efficacy of focused ultrasound (FUS) neuromodulation delivered using the Next Generation Dome Helmet (NGDH) in participants with treatment-refractory obsessive-compulsive disorder (OCD). Participants will undergo two study sessions, four weeks apart, involving active FUS neuromodulation targeting nodes of the cortico-striato-thalamo-cortical (CTSC) circuit. Outcomes include adverse events, changes in OCD symptom severity, and quality of life.
This description comes directly from the study's public registry record.
Nir Lipsman, MD, PHD, FRCSC, FAANS · (416)-480-6954 · Nir.Lipsman@sunnybrook.ca
Anusha Baskaran, PhD · 416-480-6100 · anusha.baskaran@sunnybrook.ca
Always discuss trial participation with your own doctor first.
| Sunnybrook Health Sciences Centre | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07704632